# Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies

> **NCT01755650** · EARLY_PHASE1 · TERMINATED · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 6 (actual)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **RADIATION:** 18F FPM

## Key facts

- **NCT ID:** NCT01755650
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2017-11-03
- **Final completion:** 2017-11-03
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** 6 patients were recuited. Due to inability of the tracer to detect regions of interest sufficiently, the trial was closed early.
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01755650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01755650, "Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01755650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*